Home
>
National Drug Code (NDC)
>
Oforta
Oforta - 0024-5820-15 - (fludarabine phosphate)
Drug Information of Oforta
| Product NDC: | 0024-5820 |
| Proprietary Name: | Oforta |
| Non Proprietary Name: | fludarabine phosphate |
| Active Ingredient(s): | 10 mg/1 & nbsp; fludarabine phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Oforta
| Product NDC: | 0024-5820 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022273 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091231 |
Package Information of Oforta
| Package NDC: | 0024-5820-15 |
| Package Description: | 3 BLISTER PACK in 1 BOTTLE (0024-5820-15) > 5 TABLET, FILM COATED in 1 BLISTER PACK (0024-5820-05) |
NDC Information of Oforta
| NDC Code | 0024-5820-15 |
| Proprietary Name | Oforta |
| Package Description | 3 BLISTER PACK in 1 BOTTLE (0024-5820-15) > 5 TABLET, FILM COATED in 1 BLISTER PACK (0024-5820-05) |
| Product NDC | 0024-5820 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fludarabine phosphate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20091231 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | FLUDARABINE PHOSPHATE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
